Inovio Jumps After Announcing Successful Zika, MERS Vaccine Studies
February 23, 2017 at 11:46 AM EST
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) said Thursday it’s observed a 100-percent antibody response in a phase I study for a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.